Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-139524
Filing Date
2017-04-26
Accepted
2017-04-26 16:20:32
Documents
3
Effectiveness Date
2017-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A d384159ddefa14a.htm DEFA14A 18408
2 GRAPHIC g384159g14i89.jpg GRAPHIC 232419
3 GRAPHIC g384159g82p77.jpg GRAPHIC 254391
  Complete submission text file 0001193125-17-139524.txt   690407
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33221 | Film No.: 17784620
SIC: 2834 Pharmaceutical Preparations